SCHEMBL7181059

SCHEMBL7181059

Cc1cc(C)c(C(=O)Pc2ccc(OCc3ccccc3)cc2OCc2ccccc2)c(C)c1.[LiH]

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.46
CASP3 P42574 2/20 0.45
SENP8 Q96LD8 2/20 0.45
SENP7 Q9BQF6 2/20 0.45
SENP6 Q9GZR1 2/20 0.45
TSPO P30536 1/20 0.45
FFAR4 Q5NUL3 1/20 0.44
PKM P14618 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NPC1 O15118 1/20 0.42
MAOA P21397 1/20 0.42
RAB9A P51151 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
FFAR1 O14842 4/20 0.41
PPARD Q03181 1/20 0.41
ALOX5 P09917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium SCHEMBL7181073 0.98 MAOB (0.46) MAOBCASP3SENP8SENP7SENP6
SCHEMBL7177769 0.92 MAOB (0.48) MAOBCASP3SENP8SENP7SENP6
SCHEMBL7188915 0.91 MAOB (0.48) MAOBCASP3SENP8SENP7SENP6
SCHEMBL7189943 0.90 NR4A2 (0.46) MAOBCASP3SENP8SENP7SENP6
Lithium SCHEMBL7177776 0.90 MAOB (0.48) MAOBCASP3SENP8SENP7SENP6
SCHEMBL7187077 0.89 MAOB (0.44) MAOBCASP3SENP8SENP7SENP6
Lithium SCHEMBL7189947 0.88 NR4A2 (0.46) MAOBCASP3SENP8SENP7SENP6
Lithium SCHEMBL7187088 0.87 MAOB (0.44) MAOBCASP3SENP8SENP7SENP6
SCHEMBL7181193 0.86 FFAR4 (0.45) MAOBTSPOFFAR4RXRARXRB
SCHEMBL7177460 0.85 MRGPRX4 (0.46) MAOBCASP3SENP8SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 MAOB 4189/4885CASP3 1942/4885SENP8 3693/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 MAOB 4319/4885CASP3 1781/4885SENP8 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.